Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Switch from IV to oral famotidine and save

    • 5 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Switch from IV to oral famotidine and save. Pharmacoecon. Outcomes News 17, 11 (1994). https://doi.org/10.1007/BF03272747

    Download citation

    Keywords

    • Cost Saving
    • Famotidine
    • Oral Formulation
    • Pilot Programme
    • Nursing Time